文献速递心脑血管急症复苏、休克与脓毒症重症综合管理与镇静镇痛

STEMI与NSTEMI所致心源性休克患者院内结局差异:基于全国数据库的分析

DIFFERENCES ON IN-HOSPITAL OUTCOMES IN PATIENTS WITH CARDIOGENIC SHOCK DUE TO STEMI VERSUS NSTEMI USING A NATIONWIDE DATABASE.
PubMed 文献 · Shock · 2025-01-01
一句话结论全国数据库回顾性队列显示,STEMI相关心源性休克较NSTEMI院内死亡率更高(34.2% vs 28.8%,aRR 1.19,95%CI 1.14-1.23),大出血更多,PCI/机械循环支持使用更多。

该研究利用2016-2019年美国全国住院患者样本数据库,纳入150,395例急性心肌梗死合并心源性休克患者,其中52.8%为STEMI,采用逆概率治疗加权比较STEMI与NSTEMI的院内管理和结局。结果显示STEMI组PCI、主动脉内球囊反搏、经皮心室辅助装置、体外膜肺氧合及机械通气使用显著更高,而冠状动脉旁路移植、肾脏替代治疗、住院时间和总费用更低。加权分析显示STEMI组院内死亡率显著高于NSTEMI组(34.2% vs 28.8%,aRR 1.19,95%CI 1.14-1.23),大出血也更高。结论提示STEMI相关心源性休克预后更差、有创支持和出血风险更高,而NSTEMI组更多使用CABG和医院资源。

要点

  • STEMI相关心源性休克院内死亡率34.2%,NSTEMI组28.8%,校正后aRR 1.19(95%CI 1.14-1.23),STEMI组显著更高。
  • STEMI组PCI、IABP、经皮心室辅助装置、ECMO和机械通气使用显著高于NSTEMI组。
  • NSTEMI组CABG、肾脏替代治疗、住院时间和总费用高于STEMI组。
  • 两组肺动脉导管置入和心脏移植无显著差异。

适用人群与场景

  • 2016-2019年全国住院患者样本数据库中,STEMI或NSTEMI合并心源性休克的住院患者。
  • 共纳入150,395例,中位年龄68岁(60-77),35%为女性,52.8%为STEMI。

研究设计与关键结果

  • 研究设计:基于全国住院患者样本数据库的回顾性队列研究,采用逆概率治疗加权分析比较STEMI与NSTEMI合并心源性休克患者的院内管理和结局。
  • 人群与样本量:共150,395例急性心肌梗死合并心源性休克患者,STEMI占52.8%,中位年龄68岁(60-77),女性35%。
  • 主要终点:逆概率治疗加权分析显示STEMI组院内死亡率显著高于NSTEMI组(34.2% vs 28.8%,aRR 1.19,95%CI 1.14-1.23)。
  • 次要终点:STEMI组大出血显著高于NSTEMI组(原文未报告具体数值);STEMI组PCI、IABP、经皮心室辅助装置、ECMO和机械通气使用显著高于NSTEMI组;NSTEMI组CABG、肾脏替代治疗、住院时间和总费用高于STEMI组;两组肺动脉导管置入和心脏移植无显著差异。

证据类型、等级与局限

  • 证据类型:基于全国住院患者样本数据库的回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于STEMI合并心源性休克患者,应认识到其院内死亡和大出血风险高于NSTEMI合并心源性休克患者(院内死亡率34.2% vs 28.8%,aRR 1.19,95%CI 1.14-1.23)。
  • STEMI组PCI、IABP、经皮心室辅助装置、ECMO和机械通气使用更多,NSTEMI组CABG和肾脏替代治疗使用更多,提示两组资源使用模式不同。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Our study aims to compare in-hospital management and outcomes in patients with cardiogenic shock due to ST-segment elevation myocardial infarction (STEMI) versus non-ST-segment elevation myocardial infarction (NSTEMI). Methods: We conducted a retrospective cohort study using the National Inpatient Sample database between 2016-2019, including patients with STEMI/NSTEMI complicated by cardiogenic shock. An inverse probability treatment weighting analysis was performed to compare in-hospital management and outcomes between patients with STEMI and NSTEMI. Adjusted relative risks (aRR) with their 95% confidence intervals (CIs) were estimated. Results: A total of 150,395 patients with cardiogenic shock due to acute myocardial infarction were included, of whom 52.8% had STEMI. The median age was 68 years (60-77) and 35% were female. Percutaneous coronary intervention, intra-aortic balloon counterpulsation, percutaneous ventricular assist device, extracorporeal membrane oxygenation, and mechanical ventilation use were significantly higher in the STEMI group compared to NSTEMI. Coronary artery bypass grafting, renal replacement therapy, length of hospital stay, and total costs were lower in the STEMI group. Pulmonary arterial catheterization and cardiac transplantation were similar between both groups. Inverse probability treatment weighting analysis showed that in-hospital mortality was significantly higher in the STEMI group compared to NSTEMI (34.2% vs. 28.8%, aRR 1.19, 95% CI 1.14-1.23) and also major bleeding. Conclusion: In conclusion, patients with cardiogenic shock due to STEMI had worse prognosis, higher use of percutaneous coronary intervention/mechanical circulatory support, and major bleeding than the NSTEMI group. In contrast, patients with NSTEMI had greater use of coronary artery bypass grafting and hospital resources.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Diaz-Arocutipa C, Bueno H, Moreno G, et al. DIFFERENCES ON IN-HOSPITAL OUTCOMES IN PATIENTS WITH CARDIOGENIC SHOCK DUE TO STEMI VERSUS NSTEMI USING A NATIONWIDE DATABASE. Shock. 2025. PMID: 39671550. doi:10.1097/SHK.0000000000002480

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。